{
    "nctId": "NCT04716764",
    "briefTitle": "Dietary Advanced Glycation End Products, Inflammation and Oxidative Stress in Breast Cancer Patients",
    "officialTitle": "Evaluation of The Relationship Between Dietary Advanced Glycation End Products With Inflammation and Oxidative Stress in Breast Cancer Patients",
    "overallStatus": "UNKNOWN",
    "conditions": "Breast Cancer, Female",
    "studyType": "OBSERVATIONAL",
    "phase": "N/A",
    "allocation": "N/A",
    "primaryPurpose": "N/A",
    "enrollmentCount": 32,
    "primaryOutcomeMeasure": "Dietary Advanced Glycation End Products Intake (kilounit/day)",
    "eligibilityCriteria": "Inclusion Criteria:\n\nClinical diagnosis of breast cancer for the first time, Non-metastatic, Written informed consent\n\nExclusion Criteria:\n\nAge \\< 19 years and \\> 64 years, Metastatic, Pregnancy, Lactation, Clinical diagnosis of moderate/severe neurological impairment, Clinical diagnosis of moderate/severe cognitive impairment, Clinical diagnosis of type 1 diabetes mellitus, Clinical diagnosis of type 2 diabetes mellitus, Refusal to participate",
    "sex": "FEMALE",
    "minimumAge": "19 Years",
    "stdAges": "ADULT"
}